Caregiver Support in the Coping of Patients Who Are Undergoing a Donor Bone Marrow Transplant
Status: | Completed |
---|---|
Conditions: | Cancer, Blood Cancer, Blood Cancer, Blood Cancer, Lymphoma, Psychiatric, Hematology, Hematology, Hematology, Leukemia |
Therapuetic Areas: | Hematology, Oncology, Psychiatry / Psychology |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 1/28/2018 |
Start Date: | February 1, 2006 |
End Date: | January 4, 2017 |
Adjustment to Illness by Survival Rates in Allogeneic Bone Marrow Transplant (BMT): The Relative Importance of Lay Care-Partner Support
RATIONALE: Questionnaires that measure coping may improve the ability to plan supportive care
for patients undergoing donor bone marrow transplant.
PURPOSE: This clinical trial is studying coping in patients who are undergoing a donor bone
marrow transplant.
for patients undergoing donor bone marrow transplant.
PURPOSE: This clinical trial is studying coping in patients who are undergoing a donor bone
marrow transplant.
OBJECTIVES:
- Investigate the relative importance of having a consistent inpatient lay care-partner
for patients undergoing allogeneic bone marrow transplantation, in terms of the effects
on modes of adjustment to illness and survival.
OUTLINE: Patients undergo a 40-minute recorded oral interview in person to provide personal
and social demographic data using a 20-item questionnaire (The Adjustment to Illness
Questionnaire-Bone Marrow Transplantation) at baseline (pre-transplant) and at day 100
post-transplant.
PROJECTED ACCRUAL: A total of 40 patients will be accrued for this study.
- Investigate the relative importance of having a consistent inpatient lay care-partner
for patients undergoing allogeneic bone marrow transplantation, in terms of the effects
on modes of adjustment to illness and survival.
OUTLINE: Patients undergo a 40-minute recorded oral interview in person to provide personal
and social demographic data using a 20-item questionnaire (The Adjustment to Illness
Questionnaire-Bone Marrow Transplantation) at baseline (pre-transplant) and at day 100
post-transplant.
PROJECTED ACCRUAL: A total of 40 patients will be accrued for this study.
DISEASE CHARACTERISTICS:
- Medically suitable for allogeneic bone marrow transplantation
PATIENT CHARACTERISTICS:
- Resides locally in the Cleveland, Ohio area
PRIOR CONCURRENT THERAPY:
- Not specified
We found this trial at
1
site
Click here to add this to my saved trials